Three decades of antiviral drugs

Thirty years ago, just three drugs were available for the treatment of viral infections, but now more than forty have been approved. What have been the guiding principles in these achievements and what might the future hold for antiviral drug development? SUPPLEMENTARY INFORMATION: The online versio...

Descripción completa

Detalles Bibliográficos
Autor principal: Clercq, Erik De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097450/
http://dx.doi.org/10.1038/nrd2485
_version_ 1783511003638530048
author Clercq, Erik De
author_facet Clercq, Erik De
author_sort Clercq, Erik De
collection PubMed
description Thirty years ago, just three drugs were available for the treatment of viral infections, but now more than forty have been approved. What have been the guiding principles in these achievements and what might the future hold for antiviral drug development? SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nrd2485) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7097450
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70974502020-03-26 Three decades of antiviral drugs Clercq, Erik De Nat Rev Drug Discov Article Thirty years ago, just three drugs were available for the treatment of viral infections, but now more than forty have been approved. What have been the guiding principles in these achievements and what might the future hold for antiviral drug development? SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nrd2485) contains supplementary material, which is available to authorized users. Nature Publishing Group UK 2007 /pmc/articles/PMC7097450/ http://dx.doi.org/10.1038/nrd2485 Text en © Nature Publishing Group 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Clercq, Erik De
Three decades of antiviral drugs
title Three decades of antiviral drugs
title_full Three decades of antiviral drugs
title_fullStr Three decades of antiviral drugs
title_full_unstemmed Three decades of antiviral drugs
title_short Three decades of antiviral drugs
title_sort three decades of antiviral drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097450/
http://dx.doi.org/10.1038/nrd2485
work_keys_str_mv AT clercqerikde threedecadesofantiviraldrugs

Ejemplares similares